STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials
In this edition of STAT's AI Prognosis: A conversation with Insitro CEO Daphne Koller on artificial intelligence in drug discovery, and other health AI news.
In this story
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
STAT (www.statnews.com), a Tier B publisher, filed this report on .
Signal breakdown
CurrentWire ranked this story 63.4 of 100 in the snapshot this page was rendered from.
- Freshness
- 31.9 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 10 of 10
- Velocity
- 0 of 5
Strongest signal: story prominence, 10 of 10. How each signal is calculated.
Filed under Health · International · News. Topics extracted from this report, with other live CurrentWire stories mentioning each: Artificial Intelligence (36), Insitro Daphne Koller (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.